Kaji H, Inukai Y, Maiguma T, Ono H, Teshima D, Hiramoto K, Makino K
Department of Clinical Pharmacy, School of Pharmacy, Shujitsu University, Nishigawara, Okayama, Japan.
J Clin Pharm Ther. 2009 Apr;34(2):197-205. doi: 10.1111/j.1365-2710.2008.00993.x.
Oral mucositis is a major severe toxic side-effect of systemic chemotherapy and irradiation in patients with cancer. Various free radical scavengers have been shown to prevent chemotherapy-induced skin necrosis. The objective of this study was to determine the antioxidant activity of a bisbenzylisoquinoline alkaloidal compound (BIQAC) and a series of chemicals, including allopurinol, used clinically for the treatment of chemotherapy-induced mucositis.
Allopurinol, melatonin, camostat mesilate, gabexate mesilate, hydroquinone and BIQAC were tested for their radical scavenging activities on four different radical species: 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) cation radical (ABTS(+)) using standard methods, and superoxide anion radical (O(2) (-)) and hydroxyl radical (OH()) using electron spin resonance.
Allopurinol had radical scavenging activity against O(2) (-) only. Melatonin had strong radical scavenging activity against ABTS(+), and weak activity against DPPH radical and OH(). Camostat mesilate had weak radical scavenging activity against OH(). Gabexate mesilate had no radical scavenging activity against any of these radicals. Hydroquinone had strong radical scavenging activity against DPPH radical and ABTS(+), and moderate activity against both O(2) (-) and OH(). BIQAC had moderate radical scavenging activity against DPPH radical, strong radical scavenging activity against ABTS(+) and O(2) (-), and weak activity against OH(*).
The BIQAC had the most braod-spectrum radical scavenging activity, suggesting that it may be effective against chemotherapy-induced mucositis. These findings also suggest that this radical-scavenging activity screening method, against four kinds of radicals, may be useful for the screening of radical scavenging activity of new natural and synthetic chemicals.
口腔黏膜炎是癌症患者全身化疗和放疗的一种主要严重毒性副作用。各种自由基清除剂已被证明可预防化疗引起的皮肤坏死。本研究的目的是确定一种双苄基异喹啉生物碱化合物(BIQAC)以及一系列临床上用于治疗化疗引起的黏膜炎的化学物质(包括别嘌醇)的抗氧化活性。
采用标准方法测试别嘌醇、褪黑素、甲磺酸卡莫司他、甲磺酸加贝酯、对苯二酚和BIQAC对四种不同自由基的清除活性:1,1 - 二苯基 - 2 - 苦基肼自由基(DPPH)和2,2'- 偶氮 - 双(3 - 乙基苯并噻唑啉 - 6 - 磺酸)阳离子自由基(ABTS(+)),并使用电子自旋共振测试超氧阴离子自由基(O(2)(-))和羟基自由基(OH())。
别嘌醇仅对O(2)(-)有自由基清除活性。褪黑素对ABTS(+)有较强的自由基清除活性,对DPPH自由基和OH()有较弱活性。甲磺酸卡莫司他对OH()有较弱的自由基清除活性。甲磺酸加贝酯对这些自由基均无清除活性。对苯二酚对DPPH自由基和ABTS(+)有较强的自由基清除活性,对O(2)(-)和OH()有中等活性。BIQAC对DPPH自由基有中等清除活性,对ABTS(+)和O(2)(-)有较强清除活性,对OH(*)有较弱活性。
BIQAC具有最广谱的自由基清除活性,表明它可能对化疗引起的黏膜炎有效。这些发现还表明,这种针对四种自由基的自由基清除活性筛选方法可能有助于筛选新的天然和合成化学物质的自由基清除活性。